Filing Details

Accession Number:
0001209191-18-041678
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-05 16:43:12
Reporting Period:
2018-07-02
Accepted Time:
2018-07-05 16:43:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884624 Orthofix International N V OFIX Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1669839 V. Bradley Niemann 3451 Plano Pkwy
Lewisville TX 75056
President Of Global Spine No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-02 2,989 $0.00 26,992 No 4 A Direct
Common Stock Acquisiton 2018-07-03 5,000 $27.37 31,992 No 4 M Direct
Common Stock Acquisiton 2018-07-03 6,250 $21.78 38,242 No 4 M Direct
Common Stock Disposition 2018-07-03 9,100 $56.94 29,142 No 4 S Direct
Common Stock Disposition 2018-07-03 2,150 $57.35 26,992 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-07-03 5,000 $0.00 5,000 $27.37
Common Stock Stock Option (right to buy) Disposition 2018-07-03 6,250 $0.00 6,250 $21.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-07-01 2023-07-01 No 4 M Direct
0 2017-09-26 2023-09-26 No 4 M Direct
Footnotes
  1. Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 2, 2018.
  2. The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on November 9,2017.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.27 to $57.25, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.27 to $57.45, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.